These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33786859)

  • 21. Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
    Chang DD; Eyreeuro HA; Abbott R; Coudreaut M; Baune BT; Shaman JA; Lavretsky H; Lenze EJ; Merrill DA; Singh AB; Mulsant BH; Reynolds CF; Müller DJ; Bousman C
    Pharmacogenomics; 2018 Nov; 19(16):1269-1284. PubMed ID: 30422065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
    Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
    Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions.
    Marshe VS; Islam F; Maciukiewicz M; Bousman C; Eyre HA; Lavretsky H; Mulsant BH; Reynolds CF; Lenze EJ; Müller DJ
    Am J Geriatr Psychiatry; 2020 Jun; 28(6):609-629. PubMed ID: 32122803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain-derived neurotrophic factor and antidepressant action: another piece of evidence from pharmacogenetics.
    Tsai SJ; Hong CJ; Liou YJ
    Pharmacogenomics; 2008 Sep; 9(9):1353-8. PubMed ID: 18781861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rare Functional Variants Associated with Antidepressant Remission in Mexican-Americans: Short title: Antidepressant remission and pharmacogenetics in Mexican-Americans.
    Wong ML; Arcos-Burgos M; Liu S; Licinio AW; Yu C; Chin EWM; Yao WD; Lu XY; Bornstein SR; Licinio J
    J Affect Disord; 2021 Jan; 279():491-500. PubMed ID: 33128939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex differences in the hypothalamic-pituitary-adrenal axis: An obstacle to antidepressant drug development?
    Kokras N; Hodes GE; Bangasser DA; Dalla C
    Br J Pharmacol; 2019 Nov; 176(21):4090-4106. PubMed ID: 31093959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenetics of antidepressant response.
    Keers R; Aitchison KJ
    Expert Rev Neurother; 2011 Jan; 11(1):101-25. PubMed ID: 21158559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized medicine in major depressive disorder -- opportunities and pitfalls.
    Miller DB; O'Callaghan JP
    Metabolism; 2013 Jan; 62 Suppl 1(0 1):S34-9. PubMed ID: 23021040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacist assessment of drug-gene interactions and drug-induced phenoconversion in major depressive disorder: a case report.
    Del Toro-Pagán NM; Matos A; Bardolia C; Michaud V; Turgeon J; Amin NS
    BMC Psychiatry; 2022 Jan; 22(1):46. PubMed ID: 35057765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall.
    Russell J; Arwood MJ; Toro-Pagán NMD; Amin NS; Cambridge MD; Turgeon J; Michaud V
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics.
    Shalimova A; Babasieva V; Chubarev VN; Tarasov VV; Schiöth HB; Mwinyi J
    Pharmacogenomics; 2021 Jun; 22(8):485-503. PubMed ID: 34018822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Copy number variants and therapeutic response to antidepressant medication in major depressive disorder.
    Tansey KE; Rucker JJ; Kavanagh DH; Guipponi M; Perroud N; Bondolfi G; Domenici E; Evans DM; Hauser J; Henigsberg N; Jerman B; Maier W; Mors O; O'Donovan M; Peters TJ; Placentino A; Rietschel M; Souery D; Aitchison KJ; Craig I; Farmer A; Wendland JR; Malafosse A; Lewis G; Kapur S; McGuffin P; Uher R
    Pharmacogenomics J; 2014 Aug; 14(4):395-9. PubMed ID: 24445990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant pharmacogenetics.
    Singh AB; Bousman CA; Ng C; Berk M
    Curr Opin Psychiatry; 2014 Jan; 27(1):43-51. PubMed ID: 24270480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications.
    Fabbri C; Serretti A
    Curr Psychiatry Rep; 2015 Jul; 17(7):50. PubMed ID: 25980509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].
    Leblé N; Radon L; Rabot M; Godart N
    Encephale; 2017 Feb; 43(1):62-68. PubMed ID: 27452149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomics of antidepressant drugs.
    Horstmann S; Binder EB
    Pharmacol Ther; 2009 Oct; 124(1):57-73. PubMed ID: 19563827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.
    Uher R; Perroud N; Ng MY; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Zagar T; Czerski PM; Jerman B; Larsen ER; Schulze TG; Zobel A; Cohen-Woods S; Pirlo K; Butler AW; Muglia P; Barnes MR; Lathrop M; Farmer A; Breen G; Aitchison KJ; Craig I; Lewis CM; McGuffin P
    Am J Psychiatry; 2010 May; 167(5):555-64. PubMed ID: 20360315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.
    Helton SG; Lohoff FW
    Pharmacogenomics; 2015; 16(5):541-53. PubMed ID: 25916524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.